Are you Dr. Gullo?
Join over one million U.S. Physicians, Nurse Practitioners and PAs, already on Doximity.
- Gain access to free telehealth tools, such as our "call shielding" and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
You already have 73 invites waiting! - Read the latest clinical news, personalized to your specialty.
Office
5008 Brittonfield Pkwy
Suite 700
East Syracuse, NY 13057Phone+1 315-472-7504Fax+1 315-479-8639
Summary
- Dr. John Gullo, MD is an oncologist in East Syracuse, New York. He is currently licensed to practice medicine in New York, North Carolina, and Maine. He is affiliated with Mid Coast Hospital, Pen Bay Medical Center, and St. Mary's Regional Medical Center.
Education & Training
Georgetown University HospitalFellowship, Medical Oncology, 1979
SUNY Upstate Medical UniversityResidency, Internal Medicine, 1972 - 1975- SUNY Upstate Medical UniversityInternship, Transitional Year, 1971 - 1972
SUNY Upstate Medical UniversityClass of 1971
Certifications & Licensure
ME State Medical License 2017 - 2025
MA State Medical License 2014 - 2023
NC State Medical License 2022 - 2022
NY State Medical License 1979 - 2020- American Board of Internal Medicine Internal Medicine
- American Board of Internal Medicine Medical Oncology
Awards, Honors, & Recognition
- CMS Meaningful Use Stage 1 Certification MOSAIQ EMR, Elekta, 2012-2013
Publications & Presentations
PubMed
- 29 citationsRandomized clinical trial of mitomycin-C with or without pretreatment with WR-2721 in patients with advanced colorectal cancer.Elizabeth Poplin, Patricia LoRusso, Jacob J. Lokich, John J. Gullo, Philip D. Leming
Cancer Chemotherapy and Pharmacology. 1994-01-01 - 1 citationsDichloromethotrexate, infusional cisplatin, and infusional 5-fluorouracil for locally advanced or metastatic non-small cell lung cancer. A MAOP study.Galen L. Wampler, James D. Ahlgren, Jacob J. Lokich, John J. Gullo, James A. Phillips
American Journal of Clinical Oncology. 1991-10-01 - 40 citationsA prospective randomized comparison of protracted infusional 5-fluorouracil with or without weekly bolus cisplatin in metastatic colorectal carcinoma. A Mid-Atlantic O...Jacob J. Lokich, James D. Ahlgren, James Cantrell, William J. Heim, Galen L. Wampler
Cancer. 1991-01-01
Professional Memberships
- Member
